Youling Gong

6PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersRehabilitationRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 21, 2025
Drug allergy history predicts early progression-free survival benefit from PD-(L)1 inhibitors in advanced non-small cell lung cancer: a retrospective cohort study.

Wenhao Zhao, Min Yu, Youling Gong

|Jun 21, 2025
Multimodal rehabilitation to improve quality of life and fatigue after radiotherapy in esophageal cancer patients: a randomized trial.

Xianyan Chen, Linjun Zhong, Jiao Wang

|Aug 15, 2023
Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non-Small Cell Lung Cancer Patients.

Xiaojuan Zhou, Laiyan Zhou, Zhuoran Yao

|Jul 31, 2023
Pericardial irradiation dose may be strongly associated with grade 4 lymphopenia and affect prognosis in patients with locally advanced esophageal cancer receiving definitive concurrent chemoradiotherapy.

Xianyan Chen, Xiaoman Tian, Xuanwei Zhang

|Dec 09, 2022
Uncertain resection of highest mediastinal lymph node positive among pN2 non-small cell lung cancer patients: survival analysis of postoperative radiotherapy and driver gene mutations.

Qianyue Deng, Huan Wang, Weigang Xiu

|May 11, 2022
The impact of antibiotic selection and interval time among advanced non-small cell lung cancer patients receiving prior antibacterial treatment and first-line chemotherapy.

Xiaoman Tian, Ting Mei, Min Yu

Pageof 1

Frequent Collaborators

2 joint publications

Lin Zhou

2 joint publications

Jianxin Xue

2 joint publications

Meijuan Huang

2 joint publications

You Lu